AUM Cardiovascular, Inc.


Contact Marie Johnson
Title CEO


The CADence device is intended for use in patients with chest pain and two or more coronary risk factors. Currently in pivotal testing to prove non-inferiority to a nuclear stress test, CADence promises to change the way stress testing is performed. CE Marking is expected in August 2014 and FDA approval in September 2015.